1-methyl-3-isobutylxanthine has been researched along with aphidicolin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, HJ; Currie, MS; McCachren, SS; Rao, KM | 1 |
1 other study(ies) available for 1-methyl-3-isobutylxanthine and aphidicolin
| Article | Year |
|---|---|
Pentoxifylline and other methyl xanthines inhibit interleukin-2 receptor expression in human lymphocytes.
Topics: 1-Methyl-3-isobutylxanthine; Aphidicolin; Calmodulin; Cells, Cultured; Cyclic AMP; Diterpenes; Histocompatibility Antigens Class I; Humans; Interleukin-2; Lymphocyte Activation; Lymphocytes; Pentoxifylline; Receptors, Interleukin-2; Receptors, Transferrin; RNA, Messenger | 1991 |